Asthma Inhaler Regulatory Relief Act

Asthma Inhaler Regulatory Relief Act - Prohibits the Environmental Protection Agency and the Food and Drug Administration from prohibiting the manufacture, distribution, or sale of metered-dose inhalers using chlorofluorocarbons unless alternatives are available that, for all user populations, are comparable in safety, effectiveness, therapeutic indications, dosage strength, costs, and retail availability. Mandates withdrawal of a proposed rulemaking and prohibits issuing any other proposal until after a specified meeting and extensive consultations with stakeholders. Requires, after that meeting: (1) a new proposed rulemaking setting forth the initial strategy for facilitating the U.S. transition to metered-dose inhalers that do not use chlorofluorocarbons; and (2) submission of the strategy to the Montreal Protocol Secretariat to fulfill U.S. obligations under a specified Protocol decision.